Tokiinshi

What is Tokiinshi?

Tokiinshi is a ten-herb Kampo formula used in Japan for chronic itching where the underlying problem is dryness rather than active inflammation. It descends from the Chinese prescription Dang Gui Yin Zi, recorded in the Ji Sheng Fang of 1253, and entered Japanese practice centuries ago. Today it is one of the standard health-insurance-covered Kampo prescriptions, most often given to older people whose skin has become thin, scaly and intensely itchy, sometimes with no rash visible at all.

The formula is built around the classical "four substances" blood-nourishing group — toki (Japanese angelica), jio (rehmannia), shakuyaku (peony) and senkyu (cnidium) — with astragalus and he-shou-wu added to reinforce that effect, and three surface-acting herbs (schizonepeta, saposhnikovia, tribulus) intended to settle the itch itself. A small amount of licorice completes it.

In Kampo terms, the target pattern is "blood deficiency with dryness": pale, dry, roughened skin, worse in winter and at night, worse after bathing, in someone who is not robust. It is deliberately not the formula for red, hot, oozing eczema — Kampo practitioners would choose something else for that. The clinical evidence behind it is real but thin: a few small Japanese studies, not large trials.

How does Tokiinshi work?

The traditional rationale is that itch in this pattern comes from skin that has lost its internal moisture and "blood nourishment", so the formula is aimed at rebuilding that rather than suppressing an inflammatory reaction. In modern terms, laboratory work suggests the constituents may influence skin barrier lipids, ceramide production and water-holding capacity, and may act on histamine-independent itch signalling — which would fit the clinical observation that it sometimes helps itch that antihistamines do not touch. These mechanisms are plausible and supported mainly by animal and cell studies, not by mechanistic work in patients, so they should be read as working hypotheses.

What forms does Tokiinshi come in?

In Japan the usual form is a freeze-dried extract granule dispensed on prescription (for example Tsumura TJ-86), packaged in 2.5 g sachets. Equivalent OTC granules and tablets are sold in Japan and exported; potency varies between manufacturers, and products sold outside Japan are not always made to the same pharmacopoeial standard. Traditional practitioners may prepare a decoction from the raw sliced herbs, which is stronger-tasting and somewhat more flexible in dosing but less consistent. Granules are the form used in almost all published Japanese clinical reports.

Where it comes from:

The parent formula, Dang Gui Yin Zi, appears in Yan Yonghe's Ji Sheng Fang (1253) as a treatment for "wind itch" of the skin arising from depleted blood. It is a modification of Si Wu Tang, the foundational blood-nourishing prescription, with anti-itch herbs added. Japanese Kampo adopted it and narrowed its use to chronic dry pruritus, particularly in the elderly. It was included in the list of Kampo extract formulas approved for national health insurance reimbursement in Japan, which is why it is prescribed routinely by dermatologists and general physicians there — a level of mainstream integration it has never had in the West.

What does Tokiinshi help with?

• Chronic pruritus in dry, elderly skin (senile xerosis): This is the core indication and the one with most supporting data. Small Japanese studies, mostly open-label and in the tens of patients, report reduced itch scores and better sleep in older adults with dry skin and no active dermatitis, often over four to eight weeks. Because these studies were not blinded and had no placebo arm, the size of the true effect is uncertain. What can be said honestly is that this is a long-standing, mainstream Kampo prescription for the problem in Japan, with encouraging but methodologically weak trial support.
• Asteatotic eczema / winter itch: Asteatotic eczema — dry, cracked skin with a fine crazy-paving pattern, typically on the shins in winter — is treated in Kampo with Tokiinshi alongside emollients. The traditional match is good: dryness, scaling, itch worse at night and after bathing. Direct trial evidence for this specific diagnosis is very limited, and emollients and topical treatment remain the first-line approach. Tokiinshi is best thought of as something a practitioner may add when moisturisers alone are not controlling the itch, not as a replacement for them.
• Dry-type atopic dermatitis in adults: Kampo practice distinguishes hot, red, weeping eczema from dry, thickened, pale eczema, and Tokiinshi is chosen for the second type. A small number of Japanese reports describe reduced itch and reduced need for topical steroids when it is added to standard care in adults with chronic dry atopic dermatitis. These are small, uncontrolled series. It should be used alongside, not instead of, dermatological treatment, and anyone with worsening or infected eczema needs medical review rather than a herbal formula.
• Haemodialysis-associated itching: Itch is common and distressing in people on dialysis, and Tokiinshi has been tried as an adjunct in Japan, with a few small studies reporting improvement in itch scores. The evidence is preliminary. Importantly, this is exactly the group in which the licorice content matters most: kidney failure impairs potassium and fluid handling, and pseudoaldosteronism can be dangerous. It should only be used under the supervision of the renal team, with electrolytes monitored, and never started independently.
• Dry, itchy skin in diabetes: Long-standing diabetes often produces dry, itchy skin, and this fits the Kampo pattern Tokiinshi addresses. Use here is traditional and by extension from the xerosis data; there is no meaningful trial evidence in diabetic pruritus specifically. Persistent itch in someone with diabetes also warrants a medical look, since it can reflect poor glucose control, kidney disease, or infection. Treat the formula as a possible comfort measure within a plan that includes proper diabetes care, not as an answer to the itch on its own.
• Itch persisting after eczema has settled: Some people continue to itch after visible inflammation has cleared, when what remains is a damaged, dry barrier. This residual, histamine-independent itch is where practitioners in Japan often reach for Tokiinshi, and laboratory work on skin barrier lipids offers a plausible rationale. Clinical evidence for this specific situation is essentially anecdotal and drawn from practice rather than trials. A trial period of four to eight weeks with review is the sensible approach; if there is no change, continuing is not justified.

What can Tokiinshi help prevent?

• Seasonal winter worsening of dry-skin itch: used in Japan as a preventive course through the cold months in people with a recurring pattern, though this practice rests on clinical custom rather than trial data
• Scratch–itch cycles and the skin damage they cause, indirectly, by reducing itch intensity enough to break the habit of scratching

What are the side effects of Tokiinshi?

• Stomach discomfort, nausea, appetite loss or loose stools: the most frequent complaints, often attributed to rehmannia (jio)
• Pseudoaldosteronism from the licorice (kanzo): low blood potassium, raised blood pressure, ankle or facial swelling, headache, weight gain from fluid — more likely with prolonged use, in older people, at higher doses, or when combined with other licorice-containing Kampo formulas
• Muscle weakness, cramps or, rarely, myopathy/rhabdomyolysis as a consequence of severe potassium depletion
• Rare liver injury: cases of hepatitis have been associated with Polygonum multiflorum (kashuu) preparations internationally — stop and seek medical advice if jaundice, dark urine, pale stools, marked fatigue or right-sided abdominal pain occur
• Rare allergic skin reactions or worsening rash
• Rare interstitial pneumonia and drug-induced liver injury have been reported with Kampo extract formulas in general (cough, breathlessness and fever warrant prompt review)

Good to know:

Tokiinshi is generally well tolerated at standard Japanese doses over short courses, but it is not a benign herbal tea. The licorice and kashuu components mean it deserves monitoring rather than casual long-term use, and it is best taken with a practitioner involved.

How much Tokiinshi should you take?

• Recommended daily: Japanese extract granules: typically 7.5 g of the standard extract per day, divided into two or three doses; older or lighter adults are often given 5 g/day. Traditional decoction doses differ and should be set by a practitioner. Not a self-diagnosis product — itch that is new, severe, or unexplained needs a medical assessment first.
• Best time of day: Split across the day, commonly morning and evening, or three times daily. If night-time itch is the main problem, the last dose is often given in the early evening.
• With or without food: Traditionally taken before meals or between meals, with warm water. If it causes stomach upset or appetite loss — the most common complaint, mainly from the rehmannia — taking it after food is a reasonable compromise.
• Time to effect: Itch intensity may begin to change within 2–4 weeks. Improvement in skin dryness and texture is slower, typically 1–3 months.
• How long to take it: Review after 4–8 weeks; if there has been no benefit, stop. Where it helps, longer courses are used in Japan, but anyone taking it beyond about three months should have blood pressure, potassium and liver enzymes checked periodically because of the licorice and kashuu content.